DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Harbeck N, Zhang H, Barrios CH. et al.
IMpassion031: Results from a phase III study of neoadjuvant (neoadj) atezolizumab + chemotherapy in early triple-negative breast cancer (TNBC).
Ann Oncol 2020;
31 (Suppl. 04) S1142-S1215
DOI: 10.1016/j.annonc.2020.08.2239.
We do not assume any responsibility for the contents of the web pages of other providers.